Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidemiology of psoriasis in hard-to-treat body locations: data from the Danish skin cohort
Alexander Egeberg, Kyoungah See, Alyssa Garrelts, et al.
BMC Dermatology (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 69

Showing 26-50 of 69 citing articles:

Neurological Complications of Biological Treatment of Psoriasis
Mateusz Ożóg, Beniamin Oskar Grabarek, Magdalena Wierzbik-Strońska, et al.
Life (2022) Vol. 12, Iss. 1, pp. 118-118
Open Access | Times Cited: 11
Quality of Life and Body Region Affected by Psoriasis: A Systematic Review
Karina Nabieva, Ronald Vender
Actas Dermo-Sifiliográficas (2022) Vol. 114, Iss. 1, pp. 33-38
Open Access | Times Cited: 11
Disease burden, symptoms, and use of analgesics in patients with psoriasis with or without psoriatic arthritis: A cross-sectional study
Nikolai Loft, Thao Thi Thu Nguyen, Lars Erik Kristensen, et al.
Journal of the American Academy of Dermatology (2021) Vol. 86, Iss. 3, pp. 590-597
Open Access | Times Cited: 14
Quality-of-Life Outcomes, Effectiveness and Tolerability of Apremilast in Patients with Plaque Psoriasis and Routine German Dermatology Care: Results from LAPIS-PSO
Kristian Reich, Bernhard Korge, Nina Magnolo, et al.
Dermatology and Therapy (2021) Vol. 12, Iss. 1, pp. 203-221
Open Access | Times Cited: 13
Part 2: Understanding the role of Malassezia spp. in skin disorders: pathogenesis of Malassezia associated skin infections
Iniobong Chukwuebuka Ikenna Ugochukwu, Wafa Rhimi, Wissal Chebil, et al.
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 11, pp. 1245-1257
Closed Access | Times Cited: 5
Changing spectrum of hair and scalp disorders over the last decade in a tertiary medical centre
Anna Lyakhovitsky, Ido Tzanani, Sarit Gilboa, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 37, Iss. 1, pp. 184-193
Closed Access | Times Cited: 8
Impact of psoriasis disease severity and special area involvement on patient-reported outcomes in the real world: an analysis from the CorEvitas psoriasis registry
Bruce Strober, Kristina Callis Duffin, Mark Lebwohl, et al.
Journal of Dermatological Treatment (2023) Vol. 35, Iss. 1
Open Access | Times Cited: 4
Matching Drug Prices to Their Clinical Benefit—The Final Frontier?
Ed Wilson, Z.Z.N. Yiu
JAMA Dermatology (2024) Vol. 160, Iss. 4, pp. 387-387
Closed Access | Times Cited: 1
Effectiveness of Ixekizumab in Chinese Patients with Moderate-Severe Plaque Psoriasis with Special Area Involvement: Subanalysis of a Prospective, Multicenter, Observational Real-World Study
Ying Li, Chengzhi Lv, Lin Dang, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 4, pp. 907-918
Open Access | Times Cited: 1
Short‐term efficacy of tildrakizumab on difficult‐to‐treat areas: a real‐world experience
Sara Cacciapuoti, Luca Potestio, Lucia Gallo, et al.
International Journal of Dermatology (2024)
Closed Access | Times Cited: 1
A 14-year registry review (2007-2020) on nail involvement among patients with psoriasis in Malaysia
Wen Foong Tan, Suganthy Robinson, Min Moon Tang
Clinics in Dermatology (2024) Vol. 42, Iss. 6, pp. 616-624
Closed Access | Times Cited: 1
Demographics, Disease Characteristics, and Treatment Patterns of Patients with Plaque Psoriasis Treated with Biological Drugs: The Experience of a Single-Centre Study in Poland
Agnieszka Kimak, Ewa Robak, Radosław Zajdel, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 24, pp. 7647-7647
Open Access | Times Cited: 1
[Artículo traducido] Calidad de vida y región corporal afectada por la psoriasis: una revisión sistemática
Karina Nabieva, Ronald Vender
Actas Dermo-Sifiliográficas (2022) Vol. 114, Iss. 1, pp. T33-T38
Open Access | Times Cited: 6
Scalp psoriasis and Dermatology Life Quality Index: A retrospective study based on 12-year data from the Malaysian Psoriasis Registry
Wei Cheng Leong, Jyh Jong Tang
Malaysian Family Physician (2022) Vol. 17, Iss. 3, pp. 84-88
Open Access | Times Cited: 6
Nail psoriasis dynamics during biologic treatment and withdrawal in patients with psoriasis who may be at high risk of developing psoriatic arthritis: a post hoc analysis of the VOYAGE 2 randomized trial
William Tillett, Alexander Egeberg, Enikö Sonkoly, et al.
Arthritis Research & Therapy (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 3
Efficacy of biologic agents for palmoplantar psoriasis: a systematic review and network meta-analysis
Sotirios G. Tsiogkas, Maria G. Grammatikopoulou, Katerina‐Maria Kontouli, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 12, pp. 1485-1498
Closed Access | Times Cited: 3
Nail Psoriasis and Quality-of-Life Measurement in Clinical Trials: Call for the Use of Nail-Specific Instruments
Christine Blome, Matthias Augustin, Toni Maria Klein
American Journal of Clinical Dermatology (2021) Vol. 22, Iss. 6, pp. 747-755
Open Access | Times Cited: 7
Comparison of the relative efficacy of different biologics in different body areas in patients with moderate to severe psoriasis receiving biologics and tofacitinib in phase 3 randomized controlled trials: a 15-year single-center experience
Chen-Pu Yeh, Yi‐Wei Huang, Tsen‐Fang Tsai
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 7, pp. 887-895
Closed Access | Times Cited: 5
Development and internal validation of a diagnostic prediction model for psoriasis severity
Mie Sylow Liljendahl, Nikolai Loft, Alexander Egeberg, et al.
Diagnostic and Prognostic Research (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 2
Challenges in Psoriatic Disease Addressed by Fixed-Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion.
Leon Kircik, Emil Tanghetti, Adam Friedman, et al.
PubMed (2023) Vol. 16, Iss. 3, pp. 21-26
Closed Access | Times Cited: 2
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and animal skin
Iniobong Chukwuebuka Ikenna Ugochukwu, Wafa Rhimi, Wissal Chebil, et al.
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 12, pp. 1327-1338
Closed Access | Times Cited: 2
Effectiveness of Brodalumab on Scalp, Palmoplantar, and Genital Psoriasis: A Descriptive Pilot Study
Luca Mastorino, Valentina Celoria, Nicole Macagno, et al.
Dermatologic Therapy (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 2
Drug survival of biologics and non‐biologics in patients affected by palmoplantar psoriasis: a “real‐world”, mono‐center experience
Giacomo Caldarola, Gennaro Marco Falco, Laura Calabrese, et al.
International Journal of Dermatology (2023) Vol. 63, Iss. 1, pp. 51-58
Open Access | Times Cited: 2
The efficiency of the combination of topical and biological therapy in the treatment of nails psoriasis: a prospective study
М. Н. Острецова, Е. И. Касихина, О. В. Жукова, et al.
Meditsinskiy sovet = Medical Council (2023), Iss. 13, pp. 32-37
Open Access | Times Cited: 1
Treatment of severely itchy scalp psoriasis and palmoplantar pustulosis with unsatisfied response to secukinumab, adalimumab or ustekinumab using upadacitinib: A report of two cases
Wenting Hu, Yue Wang, Si Zhang, et al.
The Journal of Dermatology (2023) Vol. 51, Iss. 5
Closed Access | Times Cited: 1

Scroll to top